descripcion
contenidos
Abbreviations
Table 1 Clinical approach to initial choice of antimicrobial therapy
Table 2 Recommended antimicrobial agents against selected bacteria
Table 3 Suggested duration of antibiotic therapy in immunocompetent patients
table 4 Comparison of antibacterial spectra
Table
5A Treatment option for systemic infection due to selected multi-drug resistant gram-positive bacteria
5B Treatment options for systemic infection due to selected multi-drug resistant gram-negative bacilli
Table 6 Suggested management of suspected or culture-positive community-associated methicillin-resistant S. aureus infections
Table 7 Drug desensitization methods
Table 8 Risk categories of antimicrobics in pregnancy
Table
9A Selected pharmacologic features of antimicrobial agents
9B Pharmacodynamics of antibacterials
9C Enzime -and transporter- mediated interacions of antimicrobials
Table
10A Antibiotic dosage and side-effects
10B Selected antibacterial agents-adverse reactions-overview
10C Antimicrobial agents associated with photosensitivity
10D Aminoglycoside once-daily and multiple daily dosing regimens
10E Prolonged or continuous infusion dosing of selected beta lactams
10F Inhalation antibiotics
Table
11A Treatment of fungal infections -antimicrobial agents of choice
11B Antifungal drugs: dosage, adverse effects, comments
11C At a glance summary of suggested antifungal drugs against treatable pathogenic fungi
Table
12A Treatment of mycobacterial infections
12B Dosage and adverse effects of antimycobacterial drugs
Table
13A Treatment of parasitic infections
13B Dosage and selected adverse effects of antiparasitic drug
13C Parasites that cause eosinophilia (eosinophilia in travelers)
13D Sources for hard-to-find antiparasitic drugs
Table
14A Antiviral thepapy
14B Antiviral drugs (Non-HIV)
14C At a glance summary of suggested antiviral agents against treatable pathogenic viruses
14D Antiretroviral therapy (ART) in treatment-naive adults (HIV/AIDS)
14E Antiretroviral drugs and adverse effects
14F Hepatitis A & HBV treatment
14G HCV treatment Regimens and response
Table
15A Antimicrobial prophylaxis for selected bacterial infections
15B Antibiotic prophylaxis to prevent surgical infections in adults
15C Antimicrobial prophylaxis for the prevention of bacterial endocarditis in patients with underlyng cardiac conditions
15D Management of exposure to HIV-1 and hepatitis B and C
Table 16 Prevention of selected opportunistic infections in human hematopoletic cell transplantation (HCT) or solid organ transplantation (SOT) in adults with normal renal function
Tabla
17A Dosages of antimicrobial drugs in adult patients with renal impairment
17B No dosage adjustment with renal insuffiency by category
17C Antimicrobial dosing in obesity
Tabla 18 antimicrobials and hepatic disease: dosage adjustment
Tabla 19 Tratment of CAPD PEritonitis in adults
Tabla
20A Anti.tetanus prophylaxis, wound classification, immunization
20B Rables postexposure prophylaxis
Tabla 21 Selected directory of resouces
Tabla
22A Anti-infective drug-drug interactions
22B Drug-drug interactions between non-nucleoside reverse transcriptase inhibitors (NNRTIS) and protease inhibitors
Table 23 List of generic and common trade names
Index of major entities
